Payload Information
General Information of This Payload
Payload ID | PAY0ZKZMJ |
|||||
---|---|---|---|---|---|---|
Name | PBD dimer 14b |
|||||
Synonyms |
PBD dimer 14b
Click to Show/Hide
|
|||||
Target(s) | Human Deoxyribonucleic acid (hDNA) |
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
EGFR-ADC 13b [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
6.00 pM
|
Positive EGFR expression (EGFR+++/++) | ||
Method Description |
Conjugates or free drug compounds were diluted in RPMI-1640 supplemented with heat-inactivated 10% FBS and 0.1 mg/ml gentamycin , and added to the plated cells. To determine specificity of cytotoxic activity of the conjugates an excess of unconjugated antibody was added to a separate set of diluted conjugates.
|
||||
In Vitro Model | Oral cavity squamous cell carcinoma | HSC-2 cells | CVCL_1287 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
30.00 pM
|
Positive EGFR expression (EGFR+++/++) | ||
Method Description |
Conjugates or free drug compounds were diluted in RPMI-1640 supplemented with heat-inactivated 10% FBS and 0.1 mg/ml gentamycin , and added to the plated cells. To determine specificity of cytotoxic activity of the conjugates an excess of unconjugated antibody was added to a separate set of diluted conjugates.
|
||||
In Vitro Model | Human papillomavirus-related endocervical adenocarcinoma | KB cells | CVCL_0372 | ||
Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.30 nM
|
Negative EGFR expression (EGFR-) | ||
Method Description |
Conjugates or free drug compounds were diluted in RPMI-1640 supplemented with heat-inactivated 10% FBS and 0.1 mg/ml gentamycin , and added to the plated cells. To determine specificity of cytotoxic activity of the conjugates an excess of unconjugated antibody was added to a separate set of diluted conjugates.
|
||||
In Vitro Model | Lung non-small cell carcinoma | NCI-H2110 cells | CVCL_1530 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.